A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent

Clinical trial NCT05546151 · COMPLETED

Trial details

NCT number: NCT05546151
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2022-09-28
Primary completion: 2023-04-07
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.